
0:00
38:10
Lifestyle Interventions and Biological Effects in RA First theranostic approach to treat difficult-to-treat RA Biologics after Cancer Is it Safe RA-ILD and Lung Cancer Disease Activity in RA-ILD Worse Survival, Unclear Lung Progression Infliximab Biosimilar Switching Anti-CCP Antibody Testing on the Spot
Altri episodi di "Rheumnow Podcast"



Non perdere nemmeno un episodio di “Rheumnow Podcast”. Iscriviti all'app gratuita GetPodcast.








